Experience, Creativity, and Tenacity
in the Patient's Battle Against Cancer
Toggle navigation
Home
About
Executive Leadership
Board Leadership
Board & Council Responsibilites
Board Governance
Mission Overview
History/Philosophy
Innovative Organization
Sitemap
News
ICAN News
Exon 20 Group News
Programs
Clinical Trials Advocacy
Drug Discovery Efforts
Exon 20 Group
Hispanic/Ibero Communities
Named Patient Programs
One-On-One Advocacy
PDL1 Amplifieds
Events
Volunteer
How You Can Help
Grassroots Advocacy
Alliances
Donate
Contact
Discovery Efforts
Accelerating Discovery
Special Initiatives
Medicinal Chemistry News
Medicinal Chemistry News
A sampling of journal articles written by G. Robert Pettit, PhD on novel anticancer compounds
- NIH National Library of Medicine, PubMed.gov
Volunteer. Donate. Review.
Federal Tax I.D.: EIN 86-0818253